Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
923.65
5.75
(0.63%)
< Home
< Back
Natco Pharma Ltd. News
>>
Natco Pharma - Quaterly Results
>>
Natco Pharma - Quaterly Results
>>
Natco Pharma - Quaterly Results
>>
Natco Pharma soars after filing ANDA for generic version of Erdafitinib Tablets
>>
Natco Pharma files ANDA for generic version of Erdafitinib Tablets
>>
Natco Pharma gets EIR from USFDA for Andhra Pradesh manufacturing facility
>>
Natco Pharma informs about disclosure
>>
Natco Pharma gets final nod for Tipiracil Hydrochloride and Tifluridine Tablets
>>
Natco Pharma - Quaterly Results
>>
Natco Pharma - Quaterly Results
<<
<
9
10
11
...52
>
>>